Kathryn Reddig

Kathryn Reddig has a strong background in regulatory affairs and clinical affairs in the medical field. Kathryn started their career at Medtronic Vascular as a Regulatory Affairs Associate from 2005 to 2007. Kathryn then moved to Smith & Nephew, where they worked as a Sr. Regulatory Affairs Specialist from 2007 to 2012 and as a Clinical Research Associate II from 2011 to 2011. In 2012, they joined CONMED Corporation as a Sr. Director of Global Regulatory Affairs and later became the Vice President of Global Regulatory & Clinical Affairs. During their time at CONMED Corporation, they have demonstrated their expertise and leadership in regulatory and clinical affairs. In addition to their corporate roles, Kathryn has also served as an Adjunct Faculty at Northeastern University and as a member of the Board of Directors at the Orthopedic Surgical Manufactures Association (OSMA) from 2016 to 2019. Through their work experience, Kathryn has gained in-depth knowledge and experience in global regulatory and clinical affairs.

Kathryn Reddig studied Finance for Senior Executives at Harvard Business School starting in 2015. Prior to that, they pursued a Master of Science degree in Regulatory Affairs at Northeastern University from 2006 to 2009. Kathryn obtained a Bachelor of Science degree in Biology/Pre-Medical from Rivier University between 1990 and 1994. Kathryn also holds certifications such as Lead Auditor Certification from ASQ obtained in 2016 and a RAC-US certification from the Regulatory Affairs Certification Program obtained in December 2006. Kathryn also has a certification in Regulatory Affairs from the Regulatory Affairs Professionals Society (RAPS).